Authors

• Yixin Zheng
• Xinliang Lv (ORCID: https://orcid.org/0000-0001-8177-0442)
• Yuejuan Zheng (ORCID: https://orcid.org/0000-0001-9995-4960)
• Yehua Jin (ORCID: https://orcid.org/0000-0002-8331-2506)
• Ping Jiang (ORCID: https://orcid.org/0000-0002-4097-5115)
• Yiming Shi (ORCID: https://orcid.org/0009-0009-9584-0830)
• Cen Chang (ORCID: https://orcid.org/0000-0002-7449-2613)
• Jianan Zhao
• Fuyu Zhao
• Mengru Guo (ORCID: https://orcid.org/0000-0002-0896-7182)
• Yu Shan
• Kai Wei (ORCID: https://orcid.org/0009-0000-6475-5590)
• Yunshen Li
• B. He

Institutions

• Shanghai University of Traditional Chinese Medicine (CN)
• Longhua Hospital Shanghai University of Traditional Chinese Medicine (CN)
• Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine (CN)
• Shuguang Hospital (CN)
• Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine (CN)

Publication Details

Journal

Endocrine Metabolic & Immune Disorders - Drug Targets

Published

2025-07-21

DOI

https://doi.org/10.2174/0118715303401357250707080740

Citations

1

Primary Topic

Hepatitis C virus research

Type

article

Field-Weighted Citation Impact

1.32